0001835701-20-000002.txt : 20201221 0001835701-20-000002.hdr.sgml : 20201221 20201221134832 ACCESSION NUMBER: 0001835701-20-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201221 DATE AS OF CHANGE: 20201221 EFFECTIVENESS DATE: 20201221 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Enalare Therapeutics Inc. CENTRAL INDEX KEY: 0001835701 IRS NUMBER: 853032063 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-382994 FILM NUMBER: 201403494 BUSINESS ADDRESS: STREET 1: 161 HODGE ROAD CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-325-7701 MAIL ADDRESS: STREET 1: 161 HODGE ROAD CITY: PRINCETON STATE: NJ ZIP: 08540 D/A 1 primary_doc.xml X0708 D/A LIVE 0001835701 Enalare Therapeutics Inc. 161 HODGE ROAD PRINCETON NJ NEW JERSEY 08540 609-325-7701 DELAWARE Enalare Therapeutics LLC None Corporation true 2018 Herman Cukier 161 Hodge Road Princeton NJ NEW JERSEY 08540 Executive Officer Director Joseph Pergolizzi 868 106th Avenue North Suite 8 Naples FL FLORIDA 34119 Executive Officer Director Gino Santini 161 Hodge Road Princeton NJ NEW JERSEY 08540 Director Joseph Petko 161 Hodge Road Princeton NJ NEW JERSEY 08540 Director Robert Yedid 161 Hodge Road Princeton NJ NEW JERSEY 08540 Director Daniel Motto 161 Hodge Road Princeton NJ NEW JERSEY 08540 Executive Officer Pharmaceuticals Decline to Disclose 06b true 0001835701-20-000001 true false true true true false 0 10000000 0 10000000 false 0 0 0 1400000 true Proceeds will be used for general working capital, including salaries and consulting fees payable to the executive officers, as well as to repay an affiliate of Dr. Pergolizzi for approximately $335,000 in start-up expenses incurred by the issuer. false Enalare Therapeutics Inc. /s/ Herman Cukier Herman Cukier President & CEO 2020-12-21